ENLIVEX THERAPEUTICS
Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn's Disease, and other autoimmune and inflammatory disorders. The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and... facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity. Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
ENLIVEX THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-10-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.enlivex.com
Total Employee:
11+
Status:
Active
Contact:
+972-2-5722071
Email Addresses:
[email protected]
Total Funding:
75.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box IPv6 Yoast WordPress SEO Plugin
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Venture Round - Enlivex Therapeutics
HBL Hadasit Bio Holdings
HBL Hadasit Bio Holdings investment in Venture Round - Enlivex Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Series B - Enlivex Therapeutics
HBL Hadasit Bio Holdings
HBL Hadasit Bio Holdings investment in Series B - Enlivex Therapeutics
Shai Novik
Shai Novik investment in Debt Financing - Enlivex Therapeutics
Official Site Inspections
http://www.enlivex.com Semrush global rank: 2.3 M Semrush visits lastest month: 8.17 K
- Host name: vps58004.dreamhostps.com
- IP address: 173.236.141.184
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
